Cargando…
The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis
Catatonia is a symptom seen in a variety of neuropsychiatric conditions, including anti-N-Methyl D-aspartate receptor (NMDAR) encephalitis. When associated with anti-NMDAR encephalitis, catatonia is resistant to standard therapy. However, electroconvulsive therapy (ECT) has shown promising success i...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285755/ https://www.ncbi.nlm.nih.gov/pubmed/34277291 http://dx.doi.org/10.7759/cureus.15706 |
_version_ | 1783723611388903424 |
---|---|
author | Olaleye, Kehinde T Oladunjoye, Adeolu O Otuada, David Anugwom, Gibson O Basiru, Tajudeen O Udeogu, Jennifer E Opaleye-Enakhimion, Taiwo Espiridion, Eduardo D |
author_facet | Olaleye, Kehinde T Oladunjoye, Adeolu O Otuada, David Anugwom, Gibson O Basiru, Tajudeen O Udeogu, Jennifer E Opaleye-Enakhimion, Taiwo Espiridion, Eduardo D |
author_sort | Olaleye, Kehinde T |
collection | PubMed |
description | Catatonia is a symptom seen in a variety of neuropsychiatric conditions, including anti-N-Methyl D-aspartate receptor (NMDAR) encephalitis. When associated with anti-NMDAR encephalitis, catatonia is resistant to standard therapy. However, electroconvulsive therapy (ECT) has shown promising success in management. This case report presents a 25-year-old African American female who presented to the emergency room with nervousness, sweating, insomnia, and visual and auditory hallucinations. She was treated symptomatically for anxiety but returned to the hospital after she continued to experience worsening symptoms. Her anxiety worsened, and she became more agitated, warranting an extensive workup, including magnetic resonance imaging (MRI) and electroencephalogram (EEG), which showed normal findings. She also had an anti-NMDA receptor antibodies titer done, which showed a positive titer result. She was treated with intravenous steroids, intravenous immunoglobulin G (IgG), plasma exchange, and rituximab, which did not improve her symptoms, and she was discharged home after a prolonged hospital stay. On follow-up visits, she reported worsening confusion, aggression, and suicidal behaviors. The patient was readmitted, during which she experienced catatonia and psychiatric symptoms, and her anti-NMDAR titer had increased to 1:1280. Further treatments with intravenous steroids, intravenous IgG, plasma exchange, and rituximab, including haloperidol and clonazepam, failed to improve her condition. However, her condition improved remarkably following treatment with 12 rounds of ECT. No randomized control trial has been done to demonstrate the effectiveness of ECT in the treatment of anti-NMDAR encephalitis despite various reports of the effectiveness of this treatment modality. This case report adds to the growing clinical evidence in support of the use of ECT in anti-NMDAR encephalitis patients with catatonia. ECT can be incorporated as standard protocol in the treatment of catatonia and associated psychiatric symptoms when managing a patient with anti-NMDAR encephalitis associated with catatonic features. |
format | Online Article Text |
id | pubmed-8285755 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-82857552021-07-17 The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis Olaleye, Kehinde T Oladunjoye, Adeolu O Otuada, David Anugwom, Gibson O Basiru, Tajudeen O Udeogu, Jennifer E Opaleye-Enakhimion, Taiwo Espiridion, Eduardo D Cureus Neurology Catatonia is a symptom seen in a variety of neuropsychiatric conditions, including anti-N-Methyl D-aspartate receptor (NMDAR) encephalitis. When associated with anti-NMDAR encephalitis, catatonia is resistant to standard therapy. However, electroconvulsive therapy (ECT) has shown promising success in management. This case report presents a 25-year-old African American female who presented to the emergency room with nervousness, sweating, insomnia, and visual and auditory hallucinations. She was treated symptomatically for anxiety but returned to the hospital after she continued to experience worsening symptoms. Her anxiety worsened, and she became more agitated, warranting an extensive workup, including magnetic resonance imaging (MRI) and electroencephalogram (EEG), which showed normal findings. She also had an anti-NMDA receptor antibodies titer done, which showed a positive titer result. She was treated with intravenous steroids, intravenous immunoglobulin G (IgG), plasma exchange, and rituximab, which did not improve her symptoms, and she was discharged home after a prolonged hospital stay. On follow-up visits, she reported worsening confusion, aggression, and suicidal behaviors. The patient was readmitted, during which she experienced catatonia and psychiatric symptoms, and her anti-NMDAR titer had increased to 1:1280. Further treatments with intravenous steroids, intravenous IgG, plasma exchange, and rituximab, including haloperidol and clonazepam, failed to improve her condition. However, her condition improved remarkably following treatment with 12 rounds of ECT. No randomized control trial has been done to demonstrate the effectiveness of ECT in the treatment of anti-NMDAR encephalitis despite various reports of the effectiveness of this treatment modality. This case report adds to the growing clinical evidence in support of the use of ECT in anti-NMDAR encephalitis patients with catatonia. ECT can be incorporated as standard protocol in the treatment of catatonia and associated psychiatric symptoms when managing a patient with anti-NMDAR encephalitis associated with catatonic features. Cureus 2021-06-17 /pmc/articles/PMC8285755/ /pubmed/34277291 http://dx.doi.org/10.7759/cureus.15706 Text en Copyright © 2021, Olaleye et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Neurology Olaleye, Kehinde T Oladunjoye, Adeolu O Otuada, David Anugwom, Gibson O Basiru, Tajudeen O Udeogu, Jennifer E Opaleye-Enakhimion, Taiwo Espiridion, Eduardo D The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis |
title | The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis |
title_full | The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis |
title_fullStr | The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis |
title_full_unstemmed | The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis |
title_short | The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis |
title_sort | effectiveness of electroconvulsive therapy on catatonia in a case of anti-n-methyl-d-aspartate (anti-nmda) receptor encephalitis |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285755/ https://www.ncbi.nlm.nih.gov/pubmed/34277291 http://dx.doi.org/10.7759/cureus.15706 |
work_keys_str_mv | AT olaleyekehindet theeffectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis AT oladunjoyeadeoluo theeffectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis AT otuadadavid theeffectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis AT anugwomgibsono theeffectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis AT basirutajudeeno theeffectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis AT udeogujennifere theeffectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis AT opaleyeenakhimiontaiwo theeffectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis AT espiridioneduardod theeffectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis AT olaleyekehindet effectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis AT oladunjoyeadeoluo effectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis AT otuadadavid effectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis AT anugwomgibsono effectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis AT basirutajudeeno effectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis AT udeogujennifere effectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis AT opaleyeenakhimiontaiwo effectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis AT espiridioneduardod effectivenessofelectroconvulsivetherapyoncatatoniainacaseofantinmethyldaspartateantinmdareceptorencephalitis |